Onyx Pharmaceuticals News (NASDAQ:ONXX)
| Latest Onyx Pharmaceuticals News Headlines | | Date | Time | Source | | | 07/23/2008 | 5:00PM | PRNUS | The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Pati
- Nexavar is First Approved Systemic Therapy to Treat the Disease -
WAYNE, N.J. and EMERYVILLE, Calif., July 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that The New England Journal of Medicine published results of a Phase 3 trial demonstrating... More...>> |
| 06/19/2008 | 4:30PM | PRNUS | Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
EMERYVILLE, Calif., June 19 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Jefferies 2nd Annual Healthcare Conference on Thursday, June 26, at 10:45 a.m. Eastern Time. Interested parties may access a live webcast of the presentation on our website at:
http://www.onyx-pharm.com/wt/page/event_calendar
It... More...>> |
| 06/04/2008 | 4:00PM | PRNUS | Onyx Pharmaceuticals to Present at Goldman Sachs 29th Annual Global Healthcare Conference
EMERYVILLE, Calif., June 4 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Goldman Sachs 29th Annual Global Healthcare Conference on Tuesday, June 10, at 8:40 a.m. Pacific Time. Interested parties may access a live webcast of the presentation on our website... More...>> |
| 06/02/2008 | 8:05AM | PRNUS | New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
WAYNE, N.J. and EMERYVILLE, Calif., June 2 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced the presentation of new clinical data from the early clinical trials in the development program for Nexavar(R) (sorafenib) tablets in multiple tumor... More...>> |
| 05/16/2008 | 2:30AM | PRNUS | Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
- Trial Results Confirm Efficacy for Population Most Affected by Disease -
WAYNE, N.J. and EMERYVILLE, Calif., May 16 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that Nexavar(R) (sorafenib) tablets significantly improved overall survival... More...>> |
| 05/16/2008 | 2:00AM | PRNUS | Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
WAYNE, N.J. and EMERYVILLE, Calif., May 16 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced more than 40 data presentations at the 2008 American Society of Clinical Oncology (ASCO) annual meeting demonstrating the potential for Nexavar(R) (sorafenib... More...>> |
| 05/08/2008 | 4:00PM | PRNUS | Onyx Pharmaceuticals to Present at Bank of America Health Care Conference
EMERYVILLE, Calif., May 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Bank of America Health Care Conference on Thursday, May 15, at 11:50 a.m. Pacific Time. Interested parties may access a live webcast of the presentation on our website at: http://www.onyx-pharm.com/wt/page/event_calendar
It... More...>> |
| 05/06/2008 | 4:00PM | PRNUS | Onyx Pharmaceuticals Reports 2008 First Quarter Results
Nexavar Net Sales increase 149% over First Quarter 2007
EMERYVILLE, Calif., May 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today reported its financial results for the first quarter ended March 31, 2008. Onyx reported net income of $15.4 million, or $0.27 per diluted share, for the first quarter... More...>> |
| 04/29/2008 | 4:00PM | PRNUS | Onyx Pharmaceuticals Announces First Quarter 2008 Financial Results Teleconference and Webcast
EMERYVILLE, Calif., April 29 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will webcast a teleconference with management to discuss first quarter 2008 financial results and provide a general business overview on Tuesday, May 6, 2008, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific... More...>> |
| 04/24/2008 | 5:00PM | PRNUS | Onyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
EMERYVILLE, Calif., April 24 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 1, at 8:00 a.m. Eastern Time. Interested parties may access a live web cast of the presentation on our website... More...>> |
| 03/11/2008 | 6:47PM | PRNUS | Onyx Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
EMERYVILLE, Calif., March 11 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Lehman Brothers Global Healthcare Conference on Wednesday, March 19, at 1:30 p.m. Eastern Time. Interested parties may access a live webcast of the presentation at: http://cc.talkpoint.com/LEHM002/031808a_jw/default.asp?entity=OnyxPharmaceutic... More...>> |
| 03/11/2008 | 5:37PM | PRNUS | Onyx Pharmaceuticals to Present at Cowen and Company Health Care Conference
EMERYVILLE, Calif., March 11 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Cowen and Company 28th Annual Health Care Conference on Tuesday, March 18, at 8:00 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ONXX&item_id=1779883
It... More...>> |
| 02/26/2008 | 9:05AM | PRNUS | Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
EMERYVILLE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it has appointed N. Anthony Coles, M.D., president, chief executive officer and a member of the company's board of directors, effective March 31, 2008. Dr. Coles succeeds Hollings C. Renton, who announced... More...>> |
| 02/26/2008 | 9:05AM | PRNUS | NPS Pharmaceuticals Announces Senior Management Changes
BEDMINSTER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) announced today that Dr. Tony Coles will be stepping down from his positions as president, chief executive officer and a director effective March 17, 2008 to become president, chief executive officer and a director of Onyx Pharmaceuticals... More...>> |
| 02/19/2008 | 7:00AM | PRNUS | Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial
EMERYVILLE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will webcast a teleconference with management to provide an update on Nexavar(R) (sorafenib) tablets, as well as to discuss fourth quarter and full year 2007 financial results, on Tuesday, February... More...>> |
| 02/19/2008 | 7:00AM | PRNUS | Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Annual Nexavar Net Sales Increased 125% to $372 million in 2007; Fourth Quarter Sales up 96% over same period last year
EMERYVILLE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today reported its financial results for the three and twelve months ended December 31, 2007. Onyx reported... More...>> |
| 02/18/2008 | 10:09AM | PRNUS | Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter
EMERYVILLE, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will webcast a teleconference with management to provide an update on Nexavar(R) (sorafenib) tablets, as well as to discuss fourth quarter and full year 2007 financial results, on Tuesday, February... More...>> |
| 02/18/2008 | 10:00AM | PRNUS | Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
WAYNE, N.J. and EMERYVILLE, Calif., Feb. 18 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that a Phase 3 trial evaluating Nexavar(R) (sorafenib) tablets in patients with non-small cell lung cancer (NSCLC) was stopped early following a planned interim analysis... More...>> |
| 02/14/2008 | 9:00AM | PRNUS | Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast
EMERYVILLE, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will webcast a teleconference with management to discuss fourth quarter and full year 2007 financial results and provide a business overview on Tuesday, February 19, 2008, at 5:00 p.m. Eastern Time... More...>> |
| 02/06/2008 | 4:00PM | PRNUS | Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
EMERYVILLE, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the BIO CEO & Investor Conference on Wednesday, February 13, at 11:00 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ONXX&item_id=1752428
It... More...>> |
|
|
|